Successful epicardial reperfusion with primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) can paradoxically evoke myocardial reperfusion injury, which may be signalled by temporally associated ventricular arrhythmias (VAs). We correlated reperfusion VA 'bursts' with final infarct size (IS) in patients with restored TIMI 3 flow following PCI for anterior STEMI.
Introduction
Early restoration of Thrombolysis in Myocardial Infarction (TIMI) 3 flow is the most effective reperfusion strategy for limiting myocardial infarct size (IS) and reducing mortality in patients with ST-elevation myocardial infarction (STEMI). 1 In the current era of primary percutaneous coronary intervention (PCI), TIMI 3 epicardial flow is achieved in .80% of patients, with in-hospital and 1 year mortality rates of ,5%.
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However, restoration of coronary blood flow to the ischaemic myocardium can itself evoke injury at the microvascular and myocellular level. 4 Such paradoxical myocardial reperfusion injury (RI) can diminish the beneficial effects of restored TIMI 3 flow, leading to increased IS, greater impairment of left ventricular (LV) function, or electric vulnerability, all of which may compromise clinical outcomes. 5, 6 Thus, characterizing an optimal reperfusion strategy in the setting of sustained TIMI 3 flow is of particular interest in the arena of acute STEMI treatment, 7 where investigative efforts are largely focused on surrogate electrocardiographical, serum, and imaging biomarkers that reflect microvascular perfusion and myocellular response beyond epicardial TIMI 3 flow reperfusion. 8 A novel biomarker that shows particular promise is reperfusion-induced ventricular arrhythmias (VAs), as was recently suggested in a pilot study by Engelen et al., 9 who first reported on the correlation between VAs associated with epicardial recanalization and poor mechanical recovery of the infarct zone. Reperfusion VAs may have potential as a non-invasive, clinically and scientifically useful, real-time biomarker of RI that permits new insight into the mechanisms underlying this phenomenon.
Our study of quantitative reperfusion arrhythmia analysis (QRAA) was designed to test and advance the hypothesis of Engelen et al. in an independent cohort drawn from the CAldaret ST-Elevation Myocardial Infarction (CASTEMI) primary PCI study. 10 We hypothesize that in a well-characterized cohort of anterior STEMI patients with TIMI 3 flow and ST recovery following primary PCI, the presence of quantitatively defined reperfusion-induced VA 'bursts' is a signal of adverse cellular response to infarct artery recanalization, as indicated by larger MI size at 7 days. We have formalized a more precise definition for reperfusion-induced VAs, using concomitantly acquired coronary angiography, continuous digital 12-lead ECG monitoring, and quantitative beat-to-beat Holter rhythm analyses, as recently described in detail. 11 We correlated such patient-specific VA 'bursts' (above background ventricular ectopy rates) temporally associated with precise and instantaneous evidence of the onset of reperfusion in the infarct-related artery (IRA) with final IS and LV function in patients with TIMI 3 flow restoration following primary PCI for anterior STEMI.
Methods

Study population
For our analysis, we used data from the CASTEMI study, a multicentre, randomized, double-blind trial evaluating adjunctive MCC-135 (caldaret) treatment for subjects with acute STEMI undergoing primary PCI. 10 Participating subjects had .20 min of chest pain with symptom onset ,6 h from presentation, and presented with .10 mm ST-segment elevation summed over the presenting 12-lead ECG. By protocol, all study patients had coronary angiography imaging for TIMI flow grade assessments, continuous digital 12-lead ECG and Holter monitoring, and SPECT imaging on Day 7. No drug effect on IS, ST-segment recovery, TIMI 3 flow rates, or VA rates was detected; thus, for this analysis, data for all CASTEMI patients with anterior STEMI and final TIMI 3 flow after primary PCI were pooled. Descriptive data were collected by an independent clinical research organization and subjected to quality control and validation procedures.
Angiographic TIMI flow assessment
Assessments of coronary angiography for TIMI flow grades were performed by an angiographic core laboratory (Bio-Imaging Technologies, Leiden, The Netherlands) blinded to all data except for coronary angiograms. TIMI flow was graded according to TIMI trial classifications.
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Electrocardiographic data acquisition
Continuous 24-h digital 12-lead ECG monitoring (NEMON 180þ, Northeast Monitoring, Maynard, MA, USA) was initiated prior to PCI in all subjects. 13 The NEMON system records a standard digital 
Continuous ST-segment recovery analysis
Criteria for continuously updated 12-lead ST-segment recovery analysis and correlations with IRA patency have been described in detail.
14 Briefly, determination of peak ST-segment deviation is based on the lead with greatest deviation taken from the most abnormal ECG recorded during monitoring. Transitions between periods of 50% recovery from the immediately preceding peak or ST-segment re-elevation of .150 mV over preceding recovered ST-segment levels are continuously updated until stable (i.e. sustained for at least 4 h) 50% ST-recovery.
Quantitative rhythm analysis
Holter 5 software (Northeast Monitoring, Maynard, MA, USA) was used for beat-to-beat quantitative rhythm analysis on all digital 3-lead Holter recordings, as recently described. 11 All automatically assigned waveform labels were manually verified for each cardiac cycle from each subject to ensure accurate VA capture according to predefined criteria for ECG interpretation of VAs. In order to generate quantitative VA rates over a 24 h period, total ventricular premature complex (VPC) counts were bundled into 5 min blocks for temporal correlation with stable ST-segment recovery and angiographic observations.
Reperfusion ventricular arrhythmia bursts
Characterization of 'reperfusion VA bursts' has been described in detail. 11 Briefly, quantitative VA rates over the course of Holter recordings were incorporated in a statistical outlier detection method to automatically separate outliers of VA rates ('VA bursts'), if present, from subject-specific background VA counts. 'Reperfusion VA bursts' were defined as VA bursts (i) concomitant with or subsequent to angiographic documentation of re-established TIMI 3 flow in the IRA and (ii) associated with 50% stable ST-segment recovery, without reference to pre-specified time 'window,' rhythmic content, or duration of the arrhythmia. Study subjects were dichotomously classified into the 'reperfusion VA burst' group or the 'no-burst' group. Examples of study subjects with or without reperfusion VA bursts are presented in Figure 1 . For all VA bursts, timing (by onset) after reperfusion, duration, quantity and density (per 5 min block) of VPCs, and ventricular rhythmic content (isolated VPCs, VPCs in couplets, or runs of 3 consecutive VPCs) of the bursts was characterized.
Final infarct size
Myocardial IS was assessed by single-photon emission computed tomography (SPECT) on Day 7 (or day of discharge, whichever came first).
Resting SPECT imaging was obtained with 22 -25 mCi 99m
Tc-sestamibi. Quantitative Gated SPECT and Quantitative Perfusion SPECT analytical packages (Software version 1.0, Cedars-Sinai Medical Center, Los Angeles, CA, USA) were used to analyse images at a blinded core laboratory (Bio-Imaging Technologies, Leiden, the Netherlands) with SPECT image quality for all centres being verified by the core laboratory. Where available, global LVEF assessments acquired with Day 7/discharge SPECT imaging were also included in these analyses.
Statistical analysis
'Univariable' comparisons of subject characteristics between the reperfusion VA burst group and the no-burst group were made using the two-sample Wilcoxon rank sum test for continuous variables and the Fisher exact test for dichotomous variables. A multivariable analysis (linear regression) was performed to assess whether VA bursts are associated with Day 7/discharge IS independently of known predictors for SPECT imaging final IS. 15 We used a predefined model, with Day 7/discharge IS as the dependent variable, and male sex, prior myocardial infarction, and time from symptom onset to reperfusion as independent variables. Also, although no drug effect was present in the CASTEMI study, we included study drug as an independent variable in the model to control for possible confounding. The same analysis was performed with global LVEF as the dependent variable. The results of linear regression modelling were summarized for each 'independent' variable by estimated coefficient, 95% confidence interval for the 'true' coefficient, and P-value. The coefficient summarizes change in the mean of the dependent variable (IS or global LVEF) resulting from increase by one unit of a continuous independent variable, or resulting from comparison of the displayed category to the other category for the dichotomous independent variables (e.g. burst compared with no-burst for variable 'reperfusion VA bursts'). In addition, for each multivariable model, we reported the squared multiple correlation coefficient (R 2 ), which can be interpreted as proportion of variance explained by the model. The assumption of normality of model residuals was assessed with a normal quantile-quantile Figure 1 Concomitantly acquired coronary angiography assessments of pre-and post-primary percutaneous coronary intervention TIMI flow grades in two study subjects (1A and 2A) with a total occlusion in the proximal left anterior descending artery proximal (LAD); continuous digital 12-lead electrocardiography monitoring for ST-segment recovery analysis with both subjects having 50% stable ST-segment recovery (1B and 2B); and complete beat-to-beat Holter monitoring for quantitative rhythm analysis identifying (1C) or not identifying (2C) patientspecific ventricular arrhythmia 'bursts' by using independent statistical outlier detection methodology. Cx, circumflex artery; LMA, left marginal artery.
Reperfusion VA 'bursts' predict larger IS (QQ) plot of standardized residuals, and the assumption of constant variance (homoscedasticity) with a plot of standardized residuals vs. fitted (predicted) values.
Subjects with reperfusion VA bursts were examined univariably using linear regression to determine whether timing (by onset) after reperfusion, duration, quantity, and density of VPCs, and ventricular rhythmic content (isolated VPCs, VPCs in couplets, or runs of 3 consecutive VPCs) of bursts correlated with Day 7/discharge IS.
A P-value of ,0.05 was considered statistically significant. All statistical tests were two-sided. Because of the exploratory nature of the analysis, we did not control for multiplicity of the tests performed but the main comparison of interest, burst vs. no burst, was prespecified as the research question prior to the analysis.
Results
Continuous ECG data
More than 15 000 000 cardiac cycles from .2900 h of continuous Holter monitoring were analysed from all 128 subjects with anterior STEMI who had angiographically documented TIMI grade 3 flow after primary PCI and SPECT assessments of final IS ( Figure 2) . Average time to initiation of continuous 12-lead Holter monitoring was 171 min (SD + 77) from onset of chest pain and 45 min (SD + 16) prior to primary PCI, with an average recording duration of 23.2 h/subject (IQR: 24.0 -24.0). Ventricular arrhythmias were present on Holter monitoring in 127/128 (99.2%) subjects, and reperfusion VA bursts occurred in 81/128 (63%) subjects.
Patient characteristics
Demographic and clinical descriptors for subjects with or without reperfusion VA bursts are listed in Table 1 . Characteristics were generally well-matched between groups. Subjects with bursts had significantly higher absolute peak ST-segment levels (P ¼ 0.003) and were characterized by earlier clinical presentation, with shorter time from onset of chest pain to first evidence of epicardial reperfusion (P ¼ 0.032).
Reperfusion ventricular arrhythmia burst characteristics
Qualitative and quantitative characteristics of bursts, including time of onset following first evidence of TIMI 3 flow restoration, total duration of burst episodes, VPC counts and rates, and arrhythmic classifications are listed in detail in Table 2 . The median time from reperfusion to onset of burst was 3 min, with 75% of VA bursts occurring within 43 min of reperfusion.
Prediction of Day 7/discharge infarct size
As shown in Figure 3 , the univariable analysis reveals a highly significant correlation between the presence of reperfusion VA bursts and larger Day 7/discharge IS [median, mean, (IQR): 21.0, 22.7, (11.0-34.0%) vs. 10.0, 14, (2.0-24.0%), P , 0.001]. The association of reperfusion VA bursts with larger IS remains significant (P , 0.001) after adjustment for known clinical correlates of IS ( Table 3) . The coefficient for the bursts variable in the multivariable linear regression analysis is 9.95, indicating that the average IS is 9.95% larger (absolute increase) for subjects with bursts than for those without bursts (95% CI: 4.99-14.92%).
Of the 128 subjects in this cohort, 118 had global LVEF data captured at the time of Day 7/discharge SPECT imaging (76 with bursts; 42 without bursts). Subjects with bursts were found to have a highly significant association with worse global LVEF [median, mean, (IQR): 35.5, 35.8, (28.0-42.2%) vs. 46.5, 46.2, (42.0-51.0%), P , 0.001] ( Figure 4) ; in a multivariable model, this association remained significant (P , 0.001) ( Table 4) .
Further, none of the qualitative and quantitative characteristics of VA bursts were significantly associated with larger IS, although we observed a trend (P ¼ 0.062) for larger IS to be correlated with major rhythmic content consisting of isolated VPCs, rather than couplets or runs of 3 VPCs.
Discussion
Our findings support and advance the hypothesis of Engelen et al. that VAs accompanying successful epicardial recanalization in the setting of primary PCI are a sign of RI at the microvascular and/ or myocardial cell level. Our data, which show that TIMI 3 flow restoration with 50% stable ST-segment recovery in anterior STEMI is correlated with larger myocardial IS based on the occurrence of reperfusion VA bursts, are gathered from an independent primary PCI population twice as large as that studied by Engelen et al. 9 Further, our study, which used a more refined, patientspecific definition of reperfusion VA bursts, is the first to demonstrate that this ECG biomarker remains strongly associated with IS even when other predictors are considered. Similarly, while in our work SPECT imaging IS as the primary CASTEMI study endpoint was more reliably available, the correlation of bursts with worse global LVEF noted in our study is consistent with the hypothesis of Engelen et al.'s correlating the presence of reperfusion VA with failure of the infarct zone to recover function over time despite restored TIMI 3 flow. 9 It should be noted, however, that total VA burden is driven by VAs independent of reperfusion per se. As such VAs are seen in almost 100% of patients who have quantitative Holter assessment during an MI, and because they are admixed with the 'reperfusion' burst signals themselves, they therefore represent a potential confounding factor in interpreting the 'signal' that derives specifically from the cellular response to recanalization. However, our definition of 'VA burst' specifically examines the implications of VA bursts emanating from restoration of TIMI 3 flow, and thus refines the specificity of the VPC burst signal.
Beyond TIMI 3 flow restoration
Multiple studies have confirmed contemporary success rates of .80% TIMI 3 flow restoration with primary PCI for STEMI, with the result that rates of mortality have correspondingly declined to ,5%. 3, 7, 10, 16, 17 Nonetheless, 15% of patients with successful flow restoration experience suboptimal myocardial response, characterized by larger IS and greater impairment of LV function, which in turn may lead to heart failure or malignant ventricular tachyarrhythmias. 4 -6,18 Thus, research efforts continue to focus on 'downstream' mechanisms of suboptimal reperfusion, especially RI. 4, 7 A number of potential surrogate markers have been proposed for identifying and quantifying suboptimal perfusion, including coronary Doppler flow wires, myocardial blush grade, TIMI myocardial perfusion grade, myocardial contrast echocardiography, cardiac magnetic resonance imaging, 99m Tc sestamibi SPECT, cardiac markers, and analysis of ST-segment recovery. 8, 19, 20 The usefulness of some of these surrogates, however, may be limited by timing issues, invasive risk, cumbersome logistics, limited availability, and cost. Defining reperfusion VA bursts with QRAA, however, is non-invasive and easily performed with portable digital high-fidelity continuous ECG monitors that provide simultaneous ST-segment recovery information. Reperfusion arrhythmias are mechanistically considered a harmless clinical manifestation of RI that occurs in parallel to more deleterious ones, such as no-reflow, LV remodelling, and cardiomyocyte apoptosis and necrosis. 21 Thus, if the general processes leading to the manifestation of RI in its many forms are related, as our results suggest, the potential utility of QRAA is to serve as a biosignal of myocardial RI in particular.
Reperfusion arrhythmias: from historical to contemporary clinical and prognostic implications
Controversy regarding the specific prognostic implications of reperfusion arrhythmias may largely stem from technical differences in the documentation and reporting of these phenomena in the published literatures. Particularly in human subjects, this methodological variability is confounded by the challenges of precisely defining and quantifying dynamic events such as epicardial History of chronic angina, n (%) n ¼ 81; 6 (7. reperfusion and continuous cardiac rhythm, both over time and in temporal relationship to one another. Previous studies have lacked simultaneous angiographic documentation of reperfusion, or have used 'snapshot' rather than continuous evidence of reperfusion. 22, 23 Many used sporadic sampling of cardiac rhythm or otherwise reported selected sustained VAs rather than comprehensive quantitative capture of all VAs; 24 -28 only a few smaller reports correlated angiographic recanalization and continuous rhythm capture. 9, 29, 30 Our study, which used simultaneously acquired angiographic documentation, continuous 24 h high-fidelity 12-lead ECGs and beat-to-beat Holter recordings, allowed us to accurately characterize the timing and quality of reperfusion and correlate it with quantitative analysis of all VAs. We were then able to define patient-specific VA bursts above the level of background ventricular ectopic activity, concomitant with or subsequent to angiographic TIMI 3 flow in the IRA associated with 50% stable ST-segment recovery. These methodological improvements support both the value of reperfusion VA bursts as an electric biomarker of downstream mechanisms as well as its utility for predictive models clinical outcomes associated with reperfusion.
Mechanistic implications
Two features of our analysis provide insight into mechanistic considerations of RI. First, our data suggest that earlier clinical presentation, usually considered a beneficial descriptor for mortality in STEMI patients, may also characterize a population more vulnerable to suboptimal 'downstream' response to reperfusion. This observation that reperfusion VAs are more frequent in STEMI patients who present earlier is consistent with both animal models and previous clinical observations. 31 -34 In animal models, as the duration of ischaemia increases, the occurrence of reperfusion arrhythmias progressively declines. may not only reflect RI, but could also identify patients with the greatest potential for myocardial salvage. Further study is needed to better understand the mechanistic and clinical implications of this phenomenon. Second, our data showed that higher peak ST was associated with greater incidence of reperfusion VA bursts. Mechanistically, this may imply more severe ischaemia, a larger territory at risk, or a more precipitous ST recovery, thus indicating downstream vulnerability to adverse myocardial responses to restored flow. Again, this may both identify a population of greater risk of downstream injury, and also with greater potential benefit from novel protective therapies. Further research will be necessary to elucidate the full implications of this observation.
Study limitations
This study is a post hoc analysis of a randomized clinical trial, with the limitations typically attendant upon such studies. The analysis, however, was prospectively planned across blinded data sets that included angiographic, ST-segment recovery, Holter arrhythmia, SPECT imaging, and clinical descriptor data. Our study included a modest cohort of patients with anterior STEMI undergoing primary PCI; thus, important subgroup analyses are limited by cohort size and the generalizability of our observations to nonanterior MIs or to patients treated with thrombolytic therapy and other medication must be regarded with caution. The precision we achieved in defining reperfusion arrhythmias, as well as their correlation with larger IS, remains to be validated in a larger, separate population. Further, although our data suggest that VA bursts are a signal of an adverse reaction to reperfusion and not a result of larger MIs prior to reperfusion, we acknowledge that this is an imputed conclusion that cannot be modelled directly. The question of whether reperfusion VA bursts are independent predictors of mortality and congestive heart failure in STEMI patients with TIMI 3 flow restoration must also be tested. Because of the low (,5%) rates of mortality among such patients, large cohorts will be required to achieve the statistical power necessary to identify significant associations between bursts and clinical outcomes.
Given the limitations noted earlier, our findings must be considered as exploratory or hypothesis-generating, and will require additional prospective confirmation. Nonetheless, the findings we present are drawn from the largest data set gathered to date, characterizing a novel, highly specific definition of reperfusion-induced VAs in human subjects with multiple concomitantly acquired markers, and appear to confirm the previous observations of Engelen et al. in a larger independent cohort. In addition, the primary endpoint used in this study was Day 7/discharge IS assessed with SPECT imaging, which is not only a well-established surrogate endpoint for worse outcomes in the setting of acute MI, but has been frequently used as a primary endpoint in phase-II clinical studies. 36 
Conclusion
Our study is unique in demonstrating that patient-specific reperfusion VA bursts independently predict larger final IS despite TIMI 3 flow restoration with primary PCI for anterior STEMI, and suggests that reperfusion VA bursts may prove useful as a non-invasive electrocardiographic biomarker of myocardial RI in STEMI patients. Conflict of interest: none declared.
